A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial
Julie E. Martin(National Institutes of Health), Barney S. Graham(National Institutes of Health), Michael P. Fay(National Institutes of Health), Qing Xu(National Institutes of Health), Mary E. Enama(National Institutes of Health), Theodore C. Pierson(National Institutes of Health), Gwong‐Jen J. Chang(Centers for Disease Control and Prevention), Sarah A. Hubka(National Institutes of Health), Martha Nason(National Institutes of Health), Ingelise J. Gordon(National Institute of Allergy and Infectious Diseases), Gary J. Nabel(National Institutes of Health), Robert T. Bailer(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Steve Rucker(National Institutes of Health), Phillip L. Gomez(National Institutes of Health), Mario Roederer(National Institutes of Health), Charla Andrews(National Institutes of Health), Brent S. Davis(Centers for Disease Control and Prevention), Richard A. Koup(Aaron Diamond AIDS Research Center)
Cited by 185
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k